Spelling suggestions: "subject:"mucoadhesion."" "subject:"mucoadhésion.""
31 |
Highly Shear-Thinning Mucoadhesive Hydrogels for Ophthalmic ApplicationsSheikholeslami, Paniz 04 1900 (has links)
<p>Highly shear-thinning polymers that can easily flow upon the application of shear but form gels at rest have multiple potential applications in the eye. In the front of the eye, a formulation that can easily be administered via a conventional eye dropper but form a gel within the tear film once applied would be beneficial for prolonging drug release at the front of the eye, either alone or as a medium for entrapping nanoparticles or nano-objects loaded with drugs. In the back of the eye, vitreous substitutes that can be administered through a narrow gauge needle (and, ideally, removed via the same) may be beneficial for retinal surgeries.</p> <p>The overall objective of the proposed research is to chemically modify PVP through grafting strategies to improve its viscometric and mucoadhesive properties while maintaining the beneficial properties, which make it useful in ophthalmic applications.</p> <p>N-vinylpyrrolidone is copolymerized with N-vinylformamide to produce a functionalized grafting platform P(VP-co-VF), which is then grafted with low concentrations of short hydrophobic grafts to introduce non-Newtonian flow profile to the precursor.</p> <p>For applications at the back of the eye, the hydrophobic grafted PVP can be injected into the vitreous cavity of the eye in a liquid form to form subsequently a gel-like substance and function as a substitute for the vitreous humour. For application at the front of the eye, the shear thinning properties of hydrophobic-grafted PVP is combined with the mucoadhesive properties of phenylboronic acids (PBA) to improve the bioavailability of the drugs delivered to the front of the eye with eye drops.</p> <p>Rheological characterization of the solutions has shown the potential to form gel-like materials via hydrophobic associations without sacrificing the facile injectability of the material. Targeted gelation and mucoadhesion properties can be obtained by the synthesis of polymers with desired PBA and hydrophobic graft contents.</p> / Master of Applied Science (MASc)
|
32 |
Formulation et caractérisation d'une forme buccale mucoadhésive thermogélifiante pour administration de sulfate de salbutamol / Formulation and characterization of a thermogelling mucoadhesive buccal form for salbutamol sulfate administrationZeng, Ni 21 April 2015 (has links)
Le traitement de l’asthme concerne une large population et fait appel très majoritairement à une administration par voie pulmonaire. Cette voie présente certains inconvénients qui pourraient être palliés par le recours à la voie buccale comme envisagé dans cette étude, avec une amélioration attendue de la compliance et de la biodisponibilité. Aussi ce travail a eu pour objectif de développer et caractériser une formulation mucoadhésive thermogélifiante à base de salbutamol. Au regard des contraintes liées à la voie buccale et à la prise en charge du traitement de l’asthme aigu, les principales propriétés pharmacotechniques attendues pour optimiser la biodisponibilité de cette formulation ont été : (i) une gélification optimale autour de 30°C après pulvérisation pour faciliter notamment l’administration ; (ii) des propriétés mécaniques et mucoadhésives importantes pour assurer un maintien de la forme au site d’absorption ; (iii) une cinétique de libération compatible avec le traitement de la phase aigüe de la pathologie. Le choix des excipients a été défini afin d’avoir la plus grande innocuité de la formulation finale. Les travaux expérimentaux ont mis en évidence l’intérêt de certaines techniques innovantes pour la caractérisation de ce type de formulation comme notamment l’étude de libération à l’aide de l’appareil de dissolution à flux continu, la détermination de la cytotoxicité par microscopie holographique digitale et l’évaluation de la mucoadhésion in vitro et in vivo par imagerie. Les résultats ont aussi permis de proposer des modèles mathématiques pour l’interprétation des mécanismes de libération du salbutamol et quantifier l’importance des phénomènes de diffusion et d’érosion. Les conclusions de cette étude sont favorables à la poursuite du développement en vue d’une commercialisation. / The treatment of asthma concerns a large population and generally necessitates an administration by the pulmonary route. This route has some drawbacks which could be overcome by the buccal route, like considered in this study expecting an improvement of the compliance and the bioavailability. The aim of this work was to develop and characterize a thermogelling mucoadhesive formulation containing salbutamol sulfate. The main properties of the formulation were: (i) thermogelation around 30°C to facilitate the administration by spray; (ii) strong mechanical properties and high mucoadhesive strength to maintain the formulation in situ; (iii) drug release kinetics adapted to the treatment. The excipients were selected with regard to the final formulation safety. The experimental work emphasized the great interest of certain techniques in the characterization of this kind of formulation, for example the drug release study using flow through apparatus, the cytotoxicity study using digital holographic microscopy and also the mucoadhesion study by in vivo imaging. The use of mathematical models provided a relevant understanding of drug release mechanisms. The conclusion of this study is favorable to a further development of the project for a future marketing.
|
33 |
Sistemas precursores de cristais líquidos mucoadesivos para administração intranasal de trans-resveratrol e avaliação biológica em modelo de Alzheimer induzido /January 2019 (has links)
Resumo: A doença de Alzheimer (DA) é uma doença altamente incidente na população mundial, acometendo cerca de 40 milhões de pessoas com idade igual ou superior a 65 anos, levando à perda da memória e cognição. A via nasal é uma via alternativa que pode promover a rápida absorção do fármaco, além de poder direcionar fármacos para o cérebro, e evitar o metabolismo pré-sistêmico. Porém, ela possui mecanismos de depuração mucociliar que podem eliminar rapidamente a formulação da cavidade nasal. Os sistemas nanoestruturados baseados em tensoativos (SNBT) que sofrem geleificação in situ demonstram ser uma opção interessante para viabilizar a administração de fármacos por esta via. O trans-resveratrol (RES) tem apresentado atividade no tratamento da DA, atuando sobre vias moleculares específicas, como a capacidade da inibição da formação da placa beta-amiloide (Aβ), despolimerização da placa Aβ formada durante a doença e atuando sobre o sistema colinérgico, inibindo a acetilcolinesterase e diminuindo a neuroinflamação e formação de radicais livres no cérebro. Entretanto, seu uso é limitado devido à sua insolubilidade em meio aquoso. Desta forma, a solubilização do RES em SNBT pode ser uma opção interessante para viabilizar o seu uso. O objetivo deste trabalho foi desenvolver e caracterizar sistemas precursores de cristais líquidos compostos pelos tensoativos álcool cetílico etoxilado 20 OE e propoxilado 5 OP (PPG-5-CETETH-20), ácido oleílico 20 OE (OLETH-20), ácido oleílico 3 OE (OLETH-3) e... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Alzheimer's disease (AD) is a highly incident illness in the world population, it affects about 40 million people aged 65 or over, and this pathology leads to memory and cognition loss. The nasal route is an alternative that can promote the rapid absorption of the drugs, besides to target drugs to the brain and to avoid the pre-systemic metabolism. However, it has mucociliary clearance that can rapidly eliminate the formulation existing under the nasal cavity. The surfactant-based nanostructured systems (SBNS) undergoes in situ gelling and seems to be an interesting feasible option for use by intranasal route. Trans-resveratrol (RES) has properties for the AD treatment, it acts on specific molecular pathways, such as the ability to inhibit the formation of amyloid-beta (Aβ) plaques, depolymerization of Aβ plaques developed during the progressing of disease and acting on the cholinergic system, inhibiting an acetylcholinesterase, and decreasing neuroinflammation and formation of free radicals in the brain. However, its use is limited due to insolubility in aqueous medium, however RES can be solubilized in these systems and therefore it can be an interesting option to do its viable employ. The aim of this work was to develop and characterize liquid crystal precursor systems composed of polyoxypropylene (5) polyoxyethylene (20) cetyl alcohol (PPG-5-CETETH-20), polyoxyethylene (20) oleyl alcohol (OLETH-20), polyoxyethylene (3) oleyl alcohol (OLETH- 3) and sorbitan polysorbate (PS... (Complete abstract click electronic access below) / Doutor
|
34 |
Sistemas líquido-cristalinos de monoleína e água para veiculação de antimicrobianos com aplicabilidade bucal / Liquid crystalline systems formed by monoolein and water with antimicrobial agents to buccal releaseSouza, Carla 26 March 2013 (has links)
Cristais líquidos são sistemas que se apresentam em um estado intermediário entre o estado sólido e líquido. A monoleína é um lipídio polar com capacidade de formar diferentes tipos de cristais líquidos liotrópicos na presença de água, caracterizados como fase lamelar, cúbica e hexagonal. Devido à capacidade de controlar a liberação dos fármacos incorporados e às propriedades mucoadesivas, estes sistemas são considerados potenciais veículos para a liberação controlada de fármacos na mucosa bucal. Sabendo que o desenvolvimento da cárie e doença periodontal está relacionado com a formação do biofilme, é necessário seu controle e prevenção para manutenção da saúde bucal. Dentre os agentes químicos disponíveis para prevenir e/ou diminuir a formação do biofilme, cloreto de cetilpiridínio (CCP), polihexametileno biguanida (PHMB) e Triclosan® têm sido amplamente utilizados. Em vista disso, o objetivo deste estudo foi desenvolver e caracterizar sistemas líquido-cristalinos de fase lamelar e cúbica formados por monoleína e água contendo antimicrobianos com aplicabilidade bucal. Os sistemas foram desenvolvidos usando monoleína e água e os antimicrobianos avaliados foram o CCP, o PHMB e o Triclosan®. A formação das fases líquido-cristalinas com e sem a presença de cada fármaco estudado foi identificada por microscopia de luz polarizada. Além disso, foi avaliado o intumescimento dos sistemas contendo os fármacos estudados após contato com saliva artificial; a atividade antimicrobiana e o perfil de liberação in vitro, bem como o tempo de permanência e a força de mucoadesão ex vivo em mucosa de bochecha de porco. Foi possível obter os sistemas líquido-cristalinos para os fármacos avaliados, e o intumescimento de todos os sistemas foi caracterizado como cinética de segunda ordem. Os resultados do perfil de liberação e da atividade antimicrobiana in vitro para PHMB e Triclosan® foram favoráveis para aplicação bucal, no entanto, o CCP não é adequado para veiculação neste sistema. O perfil de liberação dos fármacos à partir desses sistemas foi influenciado pelas propriedades físico-químicas e concentração dos fármacos, bem como pelo intumescimento. Ainda, a fase lamelar apresentou maior tempo de permanência que a fase cúbica e a força de mucoadesão média da fase lamelar foi de 1,02 ± 0,50 N e da fase cúbica foi de 0,45 ± 0,10 N. Logo, os sistemas líquido-cristalinos de monoleína e água são um interessante veículo com potencial para liberação controlada dos antimicrobianos PHMB e Triclosan® na mucosa bucal com o objetivo de otimizar a eficácia destes fármacos. / Liquid crystals are systems which are in an intermediate state between solids and liquids. Monoolein is a polar lipid capable of forming different types of lyotropic liquid crystals in aqueous environment, which can be classified into lamellar, cubic and hexagonal mesophases. Due to its ability to control drug release and its mucoadhesive properties, these systems have been considerated as potential vehicle to control drug release on buccal mucosa. Based on the knowledge that the development of caries and periodontal disease is related to the biofilm formation, it is necessary their control and prevention to maintain the buccal health. Among the available chemical agents to prevent and/or reduce biofilm formation, cetylpyridinium chloride (CPC), polyhexamethylene biguanide (PHMB) and Triclosan® have been widely used. Based on these facts, the objective of this study was to develop and characterize liquid-crystalline systems formed by monoolein and water, containing antimicrobial agents with buccal applicability. The systems were developed using monoolein and water, and the antimicrobial agents evaluated were CCP, PHMB and Triclosan®. The liquid-crystalline phases with and without the presence of each drug was identified by polarized light microscopy. Furthermore, it was evaluated the swelling of the systems containing the drugs studied after contact with artificial saliva; the in vitro antimicrobial activity and its release profile, as well as the residence time and ex vivo mucoadhesion strength on pig cheek mucosa. It was possible to obtain liquid-crystalline phases for all drugs, and the swelling of all systems was characterized according to second-order kinetics. The results of release profile and antimicrobial activity in vitro to PHMB and Triclosan® were favorable for buccal application, however CCP is not suitable to be released from these systems. The drug release profile from these systems was influenced by the physicochemical properties and loading of the drugs, as well as by swelling. Furthermore, the lamellar phase showed greater residence time that the cubic phase and the mucoadhesion strength average of lamellar phase was 1.02 ± 0.50 N and for cubic phase was 0.45 ± 0.10 N. Thus, the liquid crystalline systems forming by monoolein and water are an interesting vehicle with potential to control release of the PHMB and Triclosan® on the buccal mucosa in order to optimize the drug effectiveness.
|
35 |
Formulation et caractérisation d'une forme buccale mucoadhésive thermogélifiante pour administration de sulfate de salbutamol / Formulation and characterization of a thermogelling mucoadhesive buccal form for salbutamol sulfate administrationZeng, Ni 21 April 2015 (has links)
Le traitement de l’asthme concerne une large population et fait appel très majoritairement à une administration par voie pulmonaire. Cette voie présente certains inconvénients qui pourraient être palliés par le recours à la voie buccale comme envisagé dans cette étude, avec une amélioration attendue de la compliance et de la biodisponibilité. Aussi ce travail a eu pour objectif de développer et caractériser une formulation mucoadhésive thermogélifiante à base de salbutamol. Au regard des contraintes liées à la voie buccale et à la prise en charge du traitement de l’asthme aigu, les principales propriétés pharmacotechniques attendues pour optimiser la biodisponibilité de cette formulation ont été : (i) une gélification optimale autour de 30°C après pulvérisation pour faciliter notamment l’administration ; (ii) des propriétés mécaniques et mucoadhésives importantes pour assurer un maintien de la forme au site d’absorption ; (iii) une cinétique de libération compatible avec le traitement de la phase aigüe de la pathologie. Le choix des excipients a été défini afin d’avoir la plus grande innocuité de la formulation finale. Les travaux expérimentaux ont mis en évidence l’intérêt de certaines techniques innovantes pour la caractérisation de ce type de formulation comme notamment l’étude de libération à l’aide de l’appareil de dissolution à flux continu, la détermination de la cytotoxicité par microscopie holographique digitale et l’évaluation de la mucoadhésion in vitro et in vivo par imagerie. Les résultats ont aussi permis de proposer des modèles mathématiques pour l’interprétation des mécanismes de libération du salbutamol et quantifier l’importance des phénomènes de diffusion et d’érosion. Les conclusions de cette étude sont favorables à la poursuite du développement en vue d’une commercialisation. / The treatment of asthma concerns a large population and generally necessitates an administration by the pulmonary route. This route has some drawbacks which could be overcome by the buccal route, like considered in this study expecting an improvement of the compliance and the bioavailability. The aim of this work was to develop and characterize a thermogelling mucoadhesive formulation containing salbutamol sulfate. The main properties of the formulation were: (i) thermogelation around 30°C to facilitate the administration by spray; (ii) strong mechanical properties and high mucoadhesive strength to maintain the formulation in situ; (iii) drug release kinetics adapted to the treatment. The excipients were selected with regard to the final formulation safety. The experimental work emphasized the great interest of certain techniques in the characterization of this kind of formulation, for example the drug release study using flow through apparatus, the cytotoxicity study using digital holographic microscopy and also the mucoadhesion study by in vivo imaging. The use of mathematical models provided a relevant understanding of drug release mechanisms. The conclusion of this study is favorable to a further development of the project for a future marketing.
|
36 |
Efeitos da formulação mucoadesiva de Bidens pilosa L. (Asteraceae) e Curcuma longa L. (Zingiberaceae) no tratamento da mucosite intestinal / Effects of mucoadhesisee formulation of Bidens pilasa L. (Asteraceae) and Curcuma longa (Zingiberaceae) for treating intestitnal mucositisBastos, Carla Caroline Cunha 11 April 2014 (has links)
Submitted by Cássia Santos (cassia.bcufg@gmail.com) on 2015-02-04T10:49:57Z
No. of bitstreams: 2
Dissertação - Carla Caroline Cunha Bastos - 2014.pdf: 2798020 bytes, checksum: 01f91c35952b2cac65bd16b118d8967a (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-02-05T14:20:06Z (GMT) No. of bitstreams: 2
Dissertação - Carla Caroline Cunha Bastos - 2014.pdf: 2798020 bytes, checksum: 01f91c35952b2cac65bd16b118d8967a (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-02-05T14:20:06Z (GMT). No. of bitstreams: 2
Dissertação - Carla Caroline Cunha Bastos - 2014.pdf: 2798020 bytes, checksum: 01f91c35952b2cac65bd16b118d8967a (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Previous issue date: 2014-04-11 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Intestinal mucositis is a limiting factor in anticancer therapies by causing
gastrointestinal cell destruction reaching the majority of patients undergoing
chemotherapy/radiotherapy and is often responsible for treatment discontinuation.
Although several studies have already been conducted to treat this disease, there
are still no universally accepted and standardized protocols of treatment. Plant
species with anti-inflammatory and antioxidant properties have been considered for
the treatment of mucositis, among them Bidens pilosa L. (BP) (Asteraceae) and
Curcuma longa L. (CL) (Zingiberaceae). In this study, the effects of a formulation
containing plant extracts of Bidens pilosa L. (BP) and Curcuma longa L. (CL), both
with pharmaceutical technology of mucoadhesion in mice intestinal mucositis induced
by 5-fluoruoacil (5-FU) were studied. This formulation was administered orally
(gavage) for 6 days in each group of mice at doses of 75mg/kg + BP 3.75 mg / kg CL
100 mg / kg BP + 7.5 mg / kg or 125 mg CL / BP kg + 15 mg / kg CL. The treatment
with the formulations occurred during six days, and in parallel with mucositis
induction was performed with 5-FU (200 mg / kg, intraperitoneally) from day 4 to day
6. On day 7, the mice were euthanized and the duodenal portion of the intestine of
each animal was extracted to perform the histomorphometry technique. From this
analysis, the dose of 125 mg/kg mucoadhesive formulation showed best
effectiveness results and was then chosen for the realization of the other tests:
histopathology analysis, expression of Bax, Bcl-2, p53 and Ki-67 analysis via
immunohistochemistry technique; analysis of the activity of myeloperoxidase (MPO)
enzyme, and determination of malondialdehyde (MDA) levels. Furthermore, analysis
of weight change and hematologic parameters were performed. To prove safety of
the formulation, an oral toxicity test of mucoadhesive formulation, and effect
evaluation of the plant extracts on the animals’intestine not submitted to mucositis
were performed. The mucoadhesive formulation was able to assuage the
histopathological damage caused by 5-FU; reduced weight loss, reduced levels of
MPO and MDA; stimulated cell proliferation by increasing the expression of Ki-67;
besides decreasing apoptosis observed by analyzing the expression of Bax and Bcl-2. The formulation at a dose of 2000mg/kg showed no signs of toxicity. It can be
concluded that the formulation under study exerts preventive and/or therapeutic
effects to intestinal mucositis with potential to be used with associated to anticancer
treatment. / A mucosite intestinal é um fator limitante nas terapias com antineoplásicos por
ocasionar destruição celular gastrointestinal atingindo a maioria dos pacientes
submetidos à quimioterapia/radioterapia sendo muitas vezes responsável pela
interrupção do tratamento. Apesar de vários estudos já terem sido realizados para o
tratamento/prevenção desta patologia, ainda não existe nenhum protocolo
padronizado aceito universalmente e com eficácia comprovada. Espécies vegetais
com propriedades anti-inflamatórias e antioxidantes tem sido consideradas para o
tratamento da mucosite, dentre elas a Bidens pilosa L. (BP) (Asteraceae) e a
Curcuma longa L. (CL) (Zingiberaceae). Assim, neste estudo, os efeitos de uma
formulação contendo os extratos vegetais de Bidens pilosa (BP) e Curcuma longa
(CL), aliada à tecnologia farmacêutica de mucoadesão, foram estudados em animais
portadores de mucosite intestinal induzida por 5-fluorouracil (5-FU). Esta formulação
foi administrada por via oral (gavagem) durante 6 dias em cada grupo de
camundongos nas doses de 75mg/kg BP + 3,75 mg/kg CL, 100 mg/kg BP+ 7,5
mg/kg CL ou 125 mg/kg BP + 15 mg/kg CL. O tratamento com as formulações foi de
seis dias, sendo que em paralelo foi realizada a indução da mucosite com o 5-FU
(200 mg/kg, intraperitonealmente) do 4º ao 6º dia. No 7º dia, os camundongos foram
eutanasiados e a porção duodenal do intestino de cada animal foi extraída para
realização da técnica de histomorfometria. A partir dessa análise, a dose de 125
mg/kg da formulação mucoadesiva obteve melhores resultados e foi escolhida então
para a realização dos demais testes: análise histopatológica; análise da expressão
de Bax, Bcl-2, p53 e Ki-67 pela técnica de imunohistoquímica; avaliação da atividade
da enzima mieloperoxidase (MPO); e determinação dos níveis de malondialdeído
(MDA). Além disso, foi realizada a análise de variação ponderal e a análise
hematológica. Para comprovação da segurança da formulação estudada, foi
realizado um teste de toxidade oral aguda da formulação mucoadesiva, e avaliação
do efeito dos extratos vegetais sobre o intestino dos animais não submetidos à
mucosite intestinal. A formulação mucoadesiva foi capaz de amenizar os danos
histopatológicos causados pelo 5-FU; reduziu a perda de peso corporal, reduziu os
níveis de MPO e MDA; estimulou proliferação celular verificada através do aumento
da expressão de Ki-67; além de diminuir a apoptose observada através da análise
da expressão de Bax e Bcl-2. A formulação na dose de 2000mg/kg não apresentou
sinais de toxicidade. Pode-se concluir que a formulação em estudo exerce efeitos
preventivos e/ou terapêuticos frente à mucosite intestinal com potencial para ser
utilizada associada ao tratamento anticâncer.
|
37 |
Studies on a Novel Powder Formulation for Nasal Drug DeliveryFransén, Nelly January 2008 (has links)
Nasal administration has potential for the treatment of indications requiring a fast onset of effect or for drugs with low oral bioavailability. Liquid nasal sprays are relatively common, but can be associated with suboptimal absorption from the nasal cavity; this thesis shows that nasal absorption can be significantly enhanced with a dry powder formulation. It was shown that interactive mixtures, consisting of fine drug particles adhered to the surface of mucoadhesive carrier particles, could be created in a particle size suitable for nasal administration. Sodium starch glycolate (SSG), a common tablet excipient, was used as carrier material. In vitro evaluation of the formulation indicated that the mucoadhesion of the carrier was unlikely to be affected by the addition of a drug. The powder formulation did not improve the in vitro transfer of dihydroergotamine across porcine nasal mucosa compared with a liquid formulation; however, the results were associated with methodological shortcomings. The binding of model substances to SSG and three other excipients was evaluated. Ion exchange interactions were for example detected between SSG and cationic drugs, but these interactions were most extensive at low salt concentrations and should unlikely affect in vivo bioavailability at physiological salt concentrations. Absorption of the peptide drug desmopressin from the SSG nasal formulation, from a novel sublingual tablet formulation and from a commercial nasal liquid spray was evaluated in a clinical trial. While no improvement over the liquid spray was seen with the sublingual tablet, plasma concentrations after the nasal powder formulation were three times higher than those after the liquid spray. All formulations were well accepted by the volunteers. The use of currently available mucoadhesive carrier particles in interactive mixtures offers potential for a new method of producing nasal powder formulations that should also be applicable to large scale production.
|
38 |
Formulation et caractérisation d'une forme buccale mucoadhésive thermogélifiante pour administration de sulfate de salbutamol / Formulation and characterization of a thermogelling mucoadhesive buccal form for salbutamol sulfate administrationZeng, Ni 21 April 2015 (has links)
Le traitement de l’asthme concerne une large population et fait appel très majoritairement à une administration par voie pulmonaire. Cette voie présente certains inconvénients qui pourraient être palliés par le recours à la voie buccale comme envisagé dans cette étude, avec une amélioration attendue de la compliance et de la biodisponibilité. Aussi ce travail a eu pour objectif de développer et caractériser une formulation mucoadhésive thermogélifiante à base de salbutamol. Au regard des contraintes liées à la voie buccale et à la prise en charge du traitement de l’asthme aigu, les principales propriétés pharmacotechniques attendues pour optimiser la biodisponibilité de cette formulation ont été : (i) une gélification optimale autour de 30°C après pulvérisation pour faciliter notamment l’administration ; (ii) des propriétés mécaniques et mucoadhésives importantes pour assurer un maintien de la forme au site d’absorption ; (iii) une cinétique de libération compatible avec le traitement de la phase aigüe de la pathologie. Le choix des excipients a été défini afin d’avoir la plus grande innocuité de la formulation finale. Les travaux expérimentaux ont mis en évidence l’intérêt de certaines techniques innovantes pour la caractérisation de ce type de formulation comme notamment l’étude de libération à l’aide de l’appareil de dissolution à flux continu, la détermination de la cytotoxicité par microscopie holographique digitale et l’évaluation de la mucoadhésion in vitro et in vivo par imagerie. Les résultats ont aussi permis de proposer des modèles mathématiques pour l’interprétation des mécanismes de libération du salbutamol et quantifier l’importance des phénomènes de diffusion et d’érosion. Les conclusions de cette étude sont favorables à la poursuite du développement en vue d’une commercialisation. / The treatment of asthma concerns a large population and generally necessitates an administration by the pulmonary route. This route has some drawbacks which could be overcome by the buccal route, like considered in this study expecting an improvement of the compliance and the bioavailability. The aim of this work was to develop and characterize a thermogelling mucoadhesive formulation containing salbutamol sulfate. The main properties of the formulation were: (i) thermogelation around 30°C to facilitate the administration by spray; (ii) strong mechanical properties and high mucoadhesive strength to maintain the formulation in situ; (iii) drug release kinetics adapted to the treatment. The excipients were selected with regard to the final formulation safety. The experimental work emphasized the great interest of certain techniques in the characterization of this kind of formulation, for example the drug release study using flow through apparatus, the cytotoxicity study using digital holographic microscopy and also the mucoadhesion study by in vivo imaging. The use of mathematical models provided a relevant understanding of drug release mechanisms. The conclusion of this study is favorable to a further development of the project for a future marketing.
|
39 |
Sistemas líquido-cristalinos de monoleína e água para veiculação de antimicrobianos com aplicabilidade bucal / Liquid crystalline systems formed by monoolein and water with antimicrobial agents to buccal releaseCarla Souza 26 March 2013 (has links)
Cristais líquidos são sistemas que se apresentam em um estado intermediário entre o estado sólido e líquido. A monoleína é um lipídio polar com capacidade de formar diferentes tipos de cristais líquidos liotrópicos na presença de água, caracterizados como fase lamelar, cúbica e hexagonal. Devido à capacidade de controlar a liberação dos fármacos incorporados e às propriedades mucoadesivas, estes sistemas são considerados potenciais veículos para a liberação controlada de fármacos na mucosa bucal. Sabendo que o desenvolvimento da cárie e doença periodontal está relacionado com a formação do biofilme, é necessário seu controle e prevenção para manutenção da saúde bucal. Dentre os agentes químicos disponíveis para prevenir e/ou diminuir a formação do biofilme, cloreto de cetilpiridínio (CCP), polihexametileno biguanida (PHMB) e Triclosan® têm sido amplamente utilizados. Em vista disso, o objetivo deste estudo foi desenvolver e caracterizar sistemas líquido-cristalinos de fase lamelar e cúbica formados por monoleína e água contendo antimicrobianos com aplicabilidade bucal. Os sistemas foram desenvolvidos usando monoleína e água e os antimicrobianos avaliados foram o CCP, o PHMB e o Triclosan®. A formação das fases líquido-cristalinas com e sem a presença de cada fármaco estudado foi identificada por microscopia de luz polarizada. Além disso, foi avaliado o intumescimento dos sistemas contendo os fármacos estudados após contato com saliva artificial; a atividade antimicrobiana e o perfil de liberação in vitro, bem como o tempo de permanência e a força de mucoadesão ex vivo em mucosa de bochecha de porco. Foi possível obter os sistemas líquido-cristalinos para os fármacos avaliados, e o intumescimento de todos os sistemas foi caracterizado como cinética de segunda ordem. Os resultados do perfil de liberação e da atividade antimicrobiana in vitro para PHMB e Triclosan® foram favoráveis para aplicação bucal, no entanto, o CCP não é adequado para veiculação neste sistema. O perfil de liberação dos fármacos à partir desses sistemas foi influenciado pelas propriedades físico-químicas e concentração dos fármacos, bem como pelo intumescimento. Ainda, a fase lamelar apresentou maior tempo de permanência que a fase cúbica e a força de mucoadesão média da fase lamelar foi de 1,02 ± 0,50 N e da fase cúbica foi de 0,45 ± 0,10 N. Logo, os sistemas líquido-cristalinos de monoleína e água são um interessante veículo com potencial para liberação controlada dos antimicrobianos PHMB e Triclosan® na mucosa bucal com o objetivo de otimizar a eficácia destes fármacos. / Liquid crystals are systems which are in an intermediate state between solids and liquids. Monoolein is a polar lipid capable of forming different types of lyotropic liquid crystals in aqueous environment, which can be classified into lamellar, cubic and hexagonal mesophases. Due to its ability to control drug release and its mucoadhesive properties, these systems have been considerated as potential vehicle to control drug release on buccal mucosa. Based on the knowledge that the development of caries and periodontal disease is related to the biofilm formation, it is necessary their control and prevention to maintain the buccal health. Among the available chemical agents to prevent and/or reduce biofilm formation, cetylpyridinium chloride (CPC), polyhexamethylene biguanide (PHMB) and Triclosan® have been widely used. Based on these facts, the objective of this study was to develop and characterize liquid-crystalline systems formed by monoolein and water, containing antimicrobial agents with buccal applicability. The systems were developed using monoolein and water, and the antimicrobial agents evaluated were CCP, PHMB and Triclosan®. The liquid-crystalline phases with and without the presence of each drug was identified by polarized light microscopy. Furthermore, it was evaluated the swelling of the systems containing the drugs studied after contact with artificial saliva; the in vitro antimicrobial activity and its release profile, as well as the residence time and ex vivo mucoadhesion strength on pig cheek mucosa. It was possible to obtain liquid-crystalline phases for all drugs, and the swelling of all systems was characterized according to second-order kinetics. The results of release profile and antimicrobial activity in vitro to PHMB and Triclosan® were favorable for buccal application, however CCP is not suitable to be released from these systems. The drug release profile from these systems was influenced by the physicochemical properties and loading of the drugs, as well as by swelling. Furthermore, the lamellar phase showed greater residence time that the cubic phase and the mucoadhesion strength average of lamellar phase was 1.02 ± 0.50 N and for cubic phase was 0.45 ± 0.10 N. Thus, the liquid crystalline systems forming by monoolein and water are an interesting vehicle with potential to control release of the PHMB and Triclosan® on the buccal mucosa in order to optimize the drug effectiveness.
|
40 |
Role of Polymer Physicochemical Properties on in vitro MucoadhesionZhang, Qing 01 January 2020 (has links) (PDF)
Polymers with mucoadhesive properties are universally used in the development of mucoadhesive drug delivery system. Their physicochemical properties as well as the mechanisms related to their adhesive actions draw great attention for the modification of mucoadhesive properties.
In this study, relationships between physicochemical properties of hydroxypropyl methylcellulose (HPMC) compacts and mucoadhesive performance were investigated. Different commercial grades of HPMC (K3, E3, E5, E50, K4M, E4M and K15M) were prepared into compacts, and their surface hydrophilicity and hydration behavior were characterized. The in vitro mucoadhesive performance was determined by the tension strength between the compacts and different regions of mucous membrane (buccal, sublingual, stomach, and intestine). Positive correlations were found between: (1) viscosity of HPMC compacts and contact angle values measured by different simulated body fluids; (2) viscosity of HPMC compacts and in vitro mucoadhesive force; (3) contact angle values and in vitro mucoadhesive force. The hydration behavior exhibited improvement with the increasing viscosity of HPMC compacts. Moreover, the polar lipid content of each mucosa was likely an important factor affecting the mucoadhesion phenomenon.
Different ratios of ethyl cellulose (EC) was mixed with HPMC grade K15M to form combination compacts for the purpose of modifying the surface property. The mucoadhesive mechanism of both different grades of HPMC compacts and combination compacts were studied via the thermodynamic analysis of Lifshiz-van der Waals interaction and Lewis acid-base interaction. The total free energy of adhesion (〖∆G〗^TOT) provided a prediction of an overall tendency of mucoadhesion, however, the results were showing disagreement with the measured mucoadhesive force. In general, the involving of EC in the combination compacts did not give a boost to the whole mucoadhesive performance.
|
Page generated in 0.0418 seconds